Almuriva (rivastigmine): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Almuriva 4.6 mg/24h transdermal patch

Symptomatic treatment of mild to moderately severe Alzheimer's dementia.

Almuriva 9.5 mg/24h transdermal patch

Symptomatic treatment of mild to moderately severe Alzheimer's dementia.


Route of administration: opinion.traitement.transdermal
Molecule: rivastigmine

Patients' opinions on Almuriva

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.